A protein called TIGAR helps glioblastoma stem cells divide
Original title: TIGAR Maintains Mitotic Spindle Organization and βII-Tubulin Stability in Glioma Stem Cells.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done in animals, not people. Most findings at this stage never become treatments.
This was only done in lab cells and in mice, not in people.
The short version
Scientists found a protein that brain tumor stem cells need to grow, and blocking it slowed tumors in mice.
What was studied. Researchers studied a protein called TIGAR in human glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary stem cells grown in the lab. They turned the protein off in the cells, and they also tested this in mice with brain tumors.
What they found. TIGAR levels were high in human glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary tissue. Higher levels went along with more aggressive tumors and worse outcomes for patients. When the researchers turned TIGAR off, the tumor cells got stuck and could not divide properly. In mice, turning TIGAR off slowed tumor growth and the animals lived longer.
What this means, and what it doesn't
What it could mean: This points to a possible new target for future glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary drugs. It may work no matter what a tumor's p53 gene looks like. Right now it is a clue for researchers, not something a doctor can offer you.
What it doesn't mean: This does not mean there is a new treatment. The work was done in lab cells and in mice, not in people. No drug that blocks TIGAR has been tested in patients. Many findings like this never become a treatment. This is not a cure, and it will not change your care today.
Source: PubMed, July 1, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.